Scope of the Study
Cardiac markers are the biomarkers measured to evaluate heat function, which helps to early prediction or diagnosis of the disease. They are used in the diagnosis and risk stratification of patients with chest pain and suspected acute coronary syndrome (ACS). Cardiac markers are endogenous substances released in the circulation due to damage or death of cardiac myocytes when the heart is damaged or stressed. Thus cardiac marker test helps patient for early diagnosis of the heart disease.
The market study is being classified by Type (Cardiac Troponin, Creatinine Kinase, CK-MB and Myoglobin), by Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others) and major geographies with country level break-up.
Roche Diagnostics (Switzerland), Abbott Laboratories (United States), Siemens AG (Germany), BG Medicine (Cambodia), Biomerieux (France), Critical Diagnostics (United States), LSI Medience Corporation (Japan), diaDexus (United States), Danaher Corporation (United States) and Response Biomedical Corporation (Canada) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Singulex Inc. (United States), Thermo Fisher Scientific (United States), Trinity Biotech (Ireland) and Lee BioSolutions Inc. (United States).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Cardiac Marker market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Cardiac Marker market by Type, Application and Region.
On the basis of geography, the market of Cardiac Marker has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Testing, the sub-segment i.e. Laboratory Testing will boost the Cardiac Marker market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rising Prevalence of Cardiovascular Diseases
- Accuracy in the Cardiac Marker Testing
- Low Cost of the Test
- Technological Advancements Using Cardiac Biomarkers Combinations
- Technical Problems Related To Sample Collection and Storage
- Growing Research and Development Activities
- Increasing Geriatric Population Worldwide
- Issues Related To Regulatory and Reimbursement Systems
Market Leaders and their expansionary development strategies
Recently, Abbott laboratories acquired Alere Inc. to become a leader in point of care testing and significantly advancing global diagnostics presence. Abbott will be able to provide new, flexible, cost-effective, high-quality products to help health systems meet growing demand in both in-patient and out-patient settings.
Key Target AudienceCardiac Marker Test Providers, Emerging Companies, Research Institutes, Government Body & Associations and End-user
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase